38 reports

This can be attributed to the high prevalence of diseases such as HIV/ AIDS, hepatitis, Ebola, caused by viral infections.

  • Musculoskeletal Disorder
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Musculoskeletal Disorder
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Musculoskeletal Disorder
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.

He is experienced in designing and executing operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Arthritis
  • Musculoskeletal Disorder
  • United States
  • Forecast

FOR HIV/ AIDS (PHASE III), ZORCELL FOR PSORIASIS (PHASE ## RemuneX™ is a trademark of Immune Response BioPharma ## Zorcell™ is a trademark of Immune Response BioPharma ## CrohnsVax™ is a trademark of Immune Response BioPharma ## ##.

  • Musculoskeletal Disorder
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Musculoskeletal Disorder
  • Anthera Pharmaceuticals, Inc.
  • Biogen Idec Inc.
  • ImmuPharma plc
  • Merck Serono S.A.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Drug Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World
  • 5. All the trials included are unique trials.

Randomized Study with Polyunsaturated Fatty Acids N## Changes in Bone Mineral Densitometry HIV-infected Patients.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World

Hoffmann-La Roche Ltd Merck & Co Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## GlaxoSmithKline Plc DSM Biologics Holdings Inc ## ## ## ## ## ##

  • Clinical Trial
  • Endocrine Disease
  • Musculoskeletal Disorder
  • World
  • Amgen Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • World
  • Product Initiative

The company manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/ AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

  • Genitourinary System Disease
  • Musculoskeletal Disorder
  • United States
  • World
  • Aurinia Pharmaceuticals Inc.

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Musculoskeletal Disorder
  • Pharmaceutical
  • United Kingdom
  • World
  • Product Initiative
  • CYMABAY THERAPEUTICS INC
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY GENENTECH INC, H1 2018

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative
  • CymaBay Therapeutics, Inc.

Randomized Study with Polyunsaturated Fatty Acids N## Changes in Bone Mineral Densitometry HIV-infected Patients.

  • Clinical Trial
  • Drug Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Medical Biotechnology
  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

RHEUMATIC DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* RHEUMATIC DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III Phase II/ III Phase II Phase I/ II Phase I Phase ## Total United States ## ## ## ## ## ##

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pain Relief
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • World
  • Product Initiative

Patients were randomized ##:##:## to receive ## mg of emricasan, ## mg of emricasan, or placebo twice daily for ## weeks.

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative

About QUANTA Flash Calprotectin Prestizia, a wholly-owned subsidiary of Theradiag, works on fundamental research projects with the aim of developing new diagnostic markers using its microRNA platform, in the fields of oncology (rectal and ovarian cancers) and HIV/ AIDS.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • Grifols, S.A.
  • 5. All the trials included are unique trials.

Randomized Study with Polyunsaturated Fatty Acids N## Changes in Bone Mineral Densitometry HIV-infected Patients.

  • Chronic Disease
  • Clinical Trial
  • Musculoskeletal Disorder
  • World
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • Teijin Limited
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Mylan NV ## ## ## ## ## ## ## ## Parexel International Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Bristol-My

  • Arthritis
  • Medical Biotechnology
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pfizer Inc.
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

In the study, ## patients were randomized ##:##:## to receive placebo, baricitinib ## mg or baricitinib ## mg.

  • Clinical Trial
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • World
  • GlaxoSmithKline plc

Randomized Study with Polyunsaturated Fatty Acids N## Changes in Bone Mineral Densitometry HIV-infected Patients.

  • Medical Biotechnology
  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative

Diagnosing HIV/ AIDS in the initial phase of infection provides better opportunities for treatment.

  • Breast Cancer
  • Musculoskeletal Disorder
  • North America
  • United States
  • Market Size

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Immunotherapy
  • Musculoskeletal Disorder
  • Protein Therapy
  • Product Initiative
  • ChemoCentryx, Inc.

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Arthritis
  • Musculoskeletal Disorder
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.
  • PIPELINE BY IMMUNE RESPONSE BIOPHARMA, INC., H2 2016

Its products are used to treat multiple sclerosis, sepsis shock, HIV/ AIDS, rheumatoid arthritis, Crohns disease and psoriasis.

  • Hospital
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • Novartis AG
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY TEIJIN PHARMA LTD, H2 2017
  • GOUTY ARTHRITIS (GOUT) - PIPELINE BY SWEDISH ORPHAN BIOVITRUM AB, H2 2017

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Therapy
  • United States
  • Product Initiative